Climb Bio's total assets for Q3 2025 were $182.30M, a decrease of -5.24% from the previous quarter. CLYM total liabilities were $5.30M for the fiscal quarter, a -19.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.